India's GlaxoSmithKline Pharmaceuticals reported a higher adjusted third-quarter profit on Friday, led by sustained demand for its respiratory drugs and antibiotic Augmentin.

CEO Dame Emma Walmsley highlighted that GSK achieved 8% sales growth in 2024, reaching over £31 billion, with specialty medicines driving performance. Core operating profit grew 13%, supporting a ...

GSK has announced a 50/50 joint venture with leading Indian vaccines company, Biological E, for the early stage research and development of a six-in-one combination paediatric vaccine to help ...

The lawsuit claims GlaxoSmithKline replaced Flovent with an identical generic version, hurting patients whose insurance wouldn't cover it and costing taxpayers money. Arizona Attorney General Kris ...

Biopharmaceutical company GSK is growing its Massachusetts work force, announcing plans to move its vaccines research and development and infectious disease teams from suburban Maryland to ...

The photos show migrants from Mexico, Guatemala, Honduras, El Salvador and Cuba in the process of being deported. They don't show Indian migrants. But the images in the Facebook post don't show ...

Among them, the cardiac, anti-diabetic, and gastrointestinal therapies saw high value growth of 10.9 per cent, 10.2 per cent, ...

Yet GSK is clearly healing from its multiple comorbidities — the worst of which was the (now largely resolved) legal overhang related to heartburn medicine Zantac. Chief executive Emma Walmsley ...

Samay Raina is touring North America despite controversy over his YouTube show, India's Got Latent. A photo shows him playing chess backstage in Seattle amidst legal action. The controversy stems ...

Trials in China usually recruit patients faster than in the west because of the country’s large pool of people who have not ...

NEW DELHI (ANI) – In his farewell message, Eric Garcetti, the outgoing US Ambassador to India, reflected on the ... Shah Rukh Khan’s Om Shanti Om: “Picture abhi baaki hai mere dost!” ...